Early findings of the loss of cholinergic neurons and marked reduction in ACh in AD led to the subsequent development of the first drugs available for pharmacological treatment of AD, the cholinesterase inhibitors (ChEIs) such as donepezil, rivastigmine and galantamine. The gene discussed is BCHE; the disease is Alzheimer disease.